Moleculin Biotech, Inc. (MBRX) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Cost of goods sold	-33.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross profit	33.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Selling, general and administrative [+]	11.5	8.4	6.8	6.3	5.2	4.1	2.4
General and administrative	11.5	8.4	6.8	6.3	5.2	4.1	2.4	0.0
Research and development	19.0	14.4	12.8	11.0	9.7	4.5	1.5
Other operating expenses	30.6
EBITDA [+]	-28.1	-22.8	-19.5	-17.3	-15.0	-8.6	-3.9
EBITDA growth	23.3%	16.7%	12.8%	15.8%	73.2%	122.7%		-100.0%
Depreciation and amortization	0.1	0.2	0.2	0.2	0.1	0.0	0.0
EBIT [+]	-28.2	-23.0	-19.7	-17.5	-15.0	-8.7	-3.9	0.0
EBIT growth	23.0%	16.3%	12.7%	16.6%	73.6%	122.8%		-100.0%
Non-recurring items	2.4
Interest income, net [+]	0.2	0.3	0.0	0.0	0.0		0.0
Interest expense							0.0
Interest income	0.2	0.3	0.0	0.0	0.0
Other income (expense), net [+]	1.4	6.8	2.4	4.1	3.1	-1.2
Unrealized gain/loss on derivatives	1.3	6.7	2.3	4.1	3.2	-2.5
Change in fair value of warrants	1.3	6.7	2.3	4.1	3.2	-2.5
Other	0.0	0.0	0.0	0.0	0.0	0.0
Pre-tax income	-29.0	-15.9	-17.4	-13.4	-11.9	-9.8	-3.9	0.0
Income taxes	0.0	0.0	0.0	-0.2	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	1.7%	0.0%	0.0%	0.0%
Net income	-29.0	-15.9	-17.4	-13.2	-11.9	-9.8	-3.9	0.0

Basic EPS [+]	($1.01)	($0.59)	($1.76)	($1.95)	($0.46)	($0.53)	($0.40)
Growth	71.6%	-66.5%	-9.4%	324.4%	-13.2%	32.2%
Diluted EPS [+]	($1.01)	($0.59)	($1.76)	($1.95)	($0.46)	($0.53)	($0.40)
Growth	71.6%	-66.5%	-9.4%	324.4%	-13.2%	32.2%

Shares outstanding (basic) [+]	28.6	26.9	9.8	6.8	25.9	18.6	9.8
Growth	6.4%	173.0%	45.1%	-73.8%	39.5%	89.0%
Shares outstanding (diluted) [+]	28.6	26.9	9.8	6.8	25.9	18.6	9.8
Growth	6.4%	173.0%	45.1%	-73.8%	39.5%	89.0%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.